FDA to review Schumer’s concerns about YouTube stars’ Prime Energy drink

FDA to review Schumer’s concerns about YouTube stars’ Prime Energy drink


Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, August 29, 2020.

Andrew Kelly | Reuters

WASHINGTON — The Food and Drug Administration will address concerns raised by Senate Majority Leader Chuck Schumer about a caffeinated energy drink popular among teens.

An agency spokesperson said it “is reviewing the concerns” outlined in Schumer’s letter to FDA Commissioner Dr. Robert Califf about the dangers of Prime Energy, a beverage founded by YouTube stars Logan Paul and KSI.

The caffeinated form of the drink contains almost six times more caffeine than a standard 12 oz. can of Coca-Cola, according to Schumer, D-N.Y., who argues that physicians are concerned about its effects on kids’ health.

Prime Energy is not intended for anyone under the age of 18, according to a company representative. But Schumer says it is marketed toward that demographic on social media. Founders Paul and KSI also attract a younger fanbase.

The drink also “complied with all FDA guidelines before hitting the market,” the company representative said.

In a statement, the FDA said healthy adults can consume up to 400 mg of caffeine a day “without dangerous, negative health effects,” but there is no set level for children. Prime Energy boasts 200 mg of caffeine.

Pediatricians advise against the consumption of caffeine for children under 12 “and against any use of energy drinks for all children and teens,” according to the American Academy of Child & Adolescent Psychiatry.

“We encourage caregivers and families to read a product’s label before giving the product to their child,” the FDA said. “Consumers should take care when consuming for the first time a new packaged food containing added caffeine if the amount of caffeine in the food is not declared on the label.”

–CNBC’s Annika Kim Constantino contributed to this report.



Source

Abortion pill makers brace for restrictions a year after Trump’s election
Health

Abortion pill makers brace for restrictions a year after Trump’s election

Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe […]

Read More
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Health

Republicans push Obamacare tax credit alternatives as enrollment deadline looms

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025 in Miami, Florida. Joe Raedle | Getty Images With enhanced Obamacare tax credits set to expire at the end of the year, Republicans are proposing new alternatives aimed at lowering the cost of health care. Their window for doing so is rapidly […]

Read More
Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target
Health

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutide — the […]

Read More